Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use*; D002176:Candida albicans / Q000276:immunology*; D002330:Carmustine; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D007942:Leukemia, Experimental / Q000628:therapy; D008130:Lomustine; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008979:Moloney murine leukemia virus; D009607:Nitrosourea Compounds / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D009607:Nitrosourea Compounds; D008130:Lomustine; D002330:Carmustine